U. Bhatt

发表

Jackson T. Wright, P. Whelton, K. Sink, 2017, Journal of the American Society of Nephrology : JASN.

A modest proposal for improving the accuracy of creatinine-based GFR-estimating equations.

P. Hebert, L. Hebert, U. Bhatt, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Blood Culture Isolates in Hemodialysis Vascular Catheter-Related Bacteremia

U. Bhatt, Y. McCarter, C. Bailey, 2008, The American journal of the medical sciences.

Reactive Oxygen Species and EGR-1 Gene Expression in Surgical Postoperative Peritoneal Adhesions

N. Nahman, W. Melvin, C. Sen, 2004, World Journal of Surgery.

Cardiac stress test as a risk-stratification tool for posttransplant cardiac outcomes in diabetic kidney transplant recipients.

R. Pelletier, U. Bhatt, A. Rajab, 2012, Transplantation.

B. Rovin, L. Hebert, U. Bhatt, 2011, Journal of the American Society of Nephrology : JASN.

Warfarin Therapy That Results in an International Normalization Ratio above the Therapeutic Range Is Associated with Accelerated Progression of Chronic Kidney Disease

B. Rovin, L. Hebert, U. Bhatt, 2010, Nephron Clinical Practice.

Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints

B. Rovin, K. Kalunian, J. Sánchez-Guerrero, 2020, Kidney International Reports.

Catheter Outcomes in the Short‐term Inpatient Setting: A Controlled Quality Improvement Study Comparing Citrate and Heparin Lock

U. Bhatt, A. Agarwal, Sheri van Cleef, 2012, Seminars in dialysis.

Managing hyperphosphatemia in patients with chronic kidney disease on dialysis with ferric citrate: latest evidence and clinical usefulness

J. Lewis, U. Bhatt, S. Fadem, 2015, Therapeutic advances in chronic disease.

Glomerular beta-galactosidase expression following transduction with microsphere-adenoviral complexes.

N. Nahman, G. Nuovo, A. Johnson, 2002, Kidney international.

B. Rovin, L. Hebert, U. Bhatt, 2011, Kidney international.

Tolerating Increases in the Serum Creatinine following Aggressive Treatment of Chronic Kidney Disease, Hypertension and Proteinuria: Pre-Renal Success

B. Rovin, U. Bhatt, S. Hirsch, 2012, American Journal of Nephrology.

Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial.

A. Cheung, W. Ambrosius, T. Craven, 2019, European heart journal.

The risk of recurrent IgA nephropathy in a steroid‐free protocol and other modifying immunosuppression

U. Bhatt, N. Singh, K. Andreoni, 2014, Clinical transplantation.

Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial.

P. Whelton, M. Rocco, Mahboob Rahman, 2017, Annals of internal medicine.

The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury.

Javier A. Neyra, M. Rocco, A. Cheung, 2019, Kidney international.

Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).

Anna C. Porter, K. Sink, M. Rocco, 2018, American journal of kidney diseases : the official journal of the National Kidney Foundation.

PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.

S. Oparil, A. Cheung, W. Ambrosius, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Effect of Intensive and Standard Clinic‐Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT

P. Whelton, Mahboob Rahman, W. Cushman, 2019, Journal of the American Heart Association.

The Benefits of Intensive Versus Standard Blood Pressure Treatment According to Fine Particulate Matter Air Pollution Exposure: A Post Hoc Analysis of SPRINT.

M. Brauer, W. Cushman, R. Brook, 2021, Hypertension.

Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria: Post Hoc Analyses from SPRINT.

M. Rocco, D. Berlowitz, B. Freedman, 2020, Clinical journal of the American Society of Nephrology : CJASN.

Biodegradable Microparticles for in vivo Glomerular Targeting: Implications for Gene Therapy of Glomerular Disease

N. Nahman, L. Brannon-Peppas, A. Johnson, 2002 .

Which Is a Better Predictor of GFR Decline: 24-h Urine Protein or 24-h Protein–Creatinine Ratio? An Exploration of the MDRD Study Data

H. Nagaraja, B. Rovin, U. Bhatt, 2022, Frontiers in Nephrology.

THE BENEFITS OF INTENSIVE VERSUS STANDARD BLOOD PRESSURE TREATMENT ACCORDING TO FINE PARTICULATE MATTER AIR POLLUTION EXPOSURE: A POST-HOC ANALYSIS OF SPRINT

M. Brauer, D. Reboussin, W. Cushman, 2020 .

Effects of Intensive BP Control in CKD.

P. Whelton, K. Sink, M. Rocco, 2017, Journal of the American Society of Nephrology : JASN.

Blood Culture Isolates in Hemodialysis Vascular Catheter-Related Bacteremia

U. Bhatt, Y. McCarter, C. Bailey, 2008, The American journal of the medical sciences.

The risk of recurrent IgA nephropathy in a steroid‐free protocol and other modifying immunosuppression

U. Bhatt, K. Andreoni, T. Pesavento, 2014, Clinical transplantation.